Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.48
-0.27 (-3.48%)
At close: Sep 18, 2026, 4:00 PM EDT
7.42
-0.06 (-0.80%)
Pre-market: Sep 21, 2026, 7:45 AM EDT
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$645,989
Profits / Employee
-$267,040
Market Cap
594.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| ProKidney | 231 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| Scribe Therapeutics | 82 |
| CytomX Therapeutics | 69 |
| AgomAb Therapeutics NV | 62 |
PHAT News
- 4 days ago - PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
- 5 days ago - Phathom Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 11 days ago - Phathom Pharmaceuticals Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 11 days ago - Leerink starts Phathom Pharmaceuticals at Market Perform on limited upside - TheFly
- 12 days ago - Phathom Pharmaceuticals initiated with a Market Perform at Leerink - TheFly
- 19 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals price target lowered to $14 from $18 at Barclays - TheFly
- 7 weeks ago - Phathom Pharmaceuticals price target lowered to $20 from $22 at Craig-Hallum - TheFly